Newsletter Signup | Join Community
Avelumab Immunotherapy Approved for Bladder Cancer
Treatment of non-muscle invasive bladder cancers continues to improve with the use of immunotherpay.
Cancer Connect - Stage IV Bladder Cancer
Information on Recurrent Bladder Cancer
FDA approves Padcev - a novel antibody drug conjugate precision medicine for treatment of advanced bladder cancer.
FDA Grants N-803 Combo Breakthrough Therapy Status for Non-Muscle Invasive Bladder Cancer
The checkpoint inhibitor Tecentiq (atezolizumab) improves the outcomes of treatment for bladder cancer.
Vicinium promising for treatment of early stage and superficial bladder cancers.
Everywhere we look in the media, we find claims that different diets can improve our quality of life.
Stay Current With Bladder Cancer Treatment Advances & Connect with Others
FDA Approves PD-1 Checkpoint Inhibitor Opdivo for Treatment of Bladder Cancer
Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer
IDO inhibitor epacadostat and the anti-PD-1 drug Keytruda (pembrolizumab) promising in bladder cancer.
Can anyone share the experience with Keytruda? Any side effects?